Advertisement
Screener

LIGAND PHARMACEUTICALS INCORPORATED (LGNZZ) Revenues

2.8 / 5 stars · 68/120 Roast Me

LIGAND PHARMACEUTICALS INCORPORATED Revenues

LIGAND PHARMACEUTICALS INCORPORATED (LGNZZ) reported Revenues of $56.16 million for the 3-month period ending 2018-03-31, per its 10-Q filed 2018-05-09.

Discontinued › Income Statement › Revenue

us-gaap:Revenues · last filed 2018-05-09

  • LIGAND PHARMACEUTICALS INCORPORATED revenues for the quarter ending 2018-03-31 was $56.16M, a 91.88% increase year-over-year.
  • LIGAND PHARMACEUTICALS INCORPORATED revenues for the quarter ending 2017-12-31 was $50.47M, a 32.16% increase year-over-year.
  • LIGAND PHARMACEUTICALS INCORPORATED revenues for the quarter ending 2017-09-30 was $33.38M, a 54.38% increase year-over-year.
  • LIGAND PHARMACEUTICALS INCORPORATED revenues for the quarter ending 2017-06-30 was $28.00M, a 43.41% increase year-over-year.
  • LIGAND PHARMACEUTICALS INCORPORATED revenues for fiscal 2017 was $141.10M, a 29.48% increase from fiscal 2016.
  • LIGAND PHARMACEUTICALS INCORPORATED revenues for fiscal 2016 was $108.97M, a 51.53% increase from fiscal 2015.
  • LIGAND PHARMACEUTICALS INCORPORATED revenues for fiscal 2015 was $71.91M, a 11.43% increase from fiscal 2014.
  • LIGAND PHARMACEUTICALS INCORPORATED revenues for fiscal 2014 was $64.54M, a 31.78% increase from fiscal 2013.
Period endRevenues 3 monthRevenues 3 month as first filedRevenues 6 monthRevenues 9 monthRevenues 12 monthRevenues 12 month as first filed
2018-03-31$56.16M
10-Q · filed 2018-05-09
$106.62M
derived: sum of 2 quarters · filed 2018-05-09
$140.00M
derived: sum of 3 quarters · filed 2018-05-09
$167.99M
derived: sum of 4 quarters · filed 2018-05-09
2017-12-31$50.47M
10-K · filed 2018-03-01
$83.84M
derived: sum of 2 quarters · filed 2018-03-01
$111.83M
derived: sum of 3 quarters · filed 2018-03-01
$141.10M
10-K · filed 2018-03-01
2017-09-30$33.38M
10-K · filed 2018-03-01
$61.37M
derived: sum of 2 quarters · filed 2018-03-01
$90.64M
10-Q · filed 2017-11-09
$128.82M
derived: sum of 4 quarters · filed 2018-05-09
2017-06-30$28.00M
10-K · filed 2018-03-01
$57.26M
10-Q · filed 2017-08-09
$95.45M
derived: sum of 3 quarters · filed 2018-05-09
$117.07M
derived: sum of 4 quarters · filed 2018-05-09
2017-03-31$29.27M
10-Q · filed 2018-05-09
$67.45M
derived: sum of 2 quarters · filed 2018-05-09
$89.07M
derived: sum of 3 quarters · filed 2018-05-09
$108.59M
derived: sum of 4 quarters · filed 2018-05-09
2016-12-31$38.19M
10-K · filed 2018-03-01
$59.80M
derived: sum of 2 quarters · filed 2018-03-01
$79.33M
derived: sum of 3 quarters · filed 2018-03-01
$108.97M
10-K · filed 2018-03-01
2016-09-30$21.62M
10-K · filed 2018-03-01
$41.14M
derived: sum of 2 quarters · filed 2018-03-01
$70.79M
10-Q · filed 2017-11-09
$91.98M
derived: sum of 4 quarters · filed 2018-03-01
2016-06-30$19.52M
10-K · filed 2018-03-01
$49.17M
10-Q · filed 2017-08-09
$70.36M
derived: sum of 3 quarters · filed 2018-03-01
$88.06M
derived: sum of 4 quarters · filed 2018-03-01
2016-03-31$29.65M
10-K · filed 2018-03-01
$50.84M
derived: sum of 2 quarters · filed 2018-03-01
$68.54M
derived: sum of 3 quarters · filed 2018-03-01
$86.96M
derived: sum of 4 quarters · filed 2018-03-01
2015-12-31$21.19M
10-K · filed 2017-02-28
$38.89M
derived: sum of 2 quarters · filed 2017-02-28
$57.31M
derived: sum of 3 quarters · filed 2017-02-28
$71.91M
10-K · filed 2018-03-01
2015-09-30$17.70M
10-K · filed 2017-02-28
$36.12M
derived: sum of 2 quarters · filed 2017-02-28
$50.72M
10-Q · filed 2016-11-14
$73.72M
derived: sum of 4 quarters · filed 2017-02-28
2015-06-30$18.42M
10-K · filed 2017-02-28
$33.02M
10-Q · filed 2016-11-14
$56.02M
derived: sum of 3 quarters · filed 2017-02-28
$70.99M
derived: sum of 4 quarters · filed 2017-02-28
2015-03-31$14.60M
10-K · filed 2017-02-28
$37.60M
derived: sum of 2 quarters · filed 2017-02-28
$52.57M
derived: sum of 3 quarters · filed 2017-02-28
$63.18M
derived: sum of 4 quarters · filed 2017-02-28
2014-12-31$23.00M
10-K · filed 2016-11-14
$14.74M
10-K · filed 2014-12-01
$37.97M
derived: sum of 2 quarters · filed 2016-11-14
$48.58M
derived: sum of 3 quarters · filed 2016-11-14
$64.54M
10-K · filed 2017-02-28
$48.97M
10-K · filed 2014-12-01
2014-09-30$14.97M
10-K · filed 2016-11-14
$25.58M
derived: sum of 2 quarters · filed 2016-11-14
$41.54M
10-Q · filed 2015-11-09
$56.28M
derived: sum of 4 quarters · filed 2016-11-14
2014-06-30$10.61M
10-K · filed 2016-11-14
$26.57M
10-Q · filed 2015-08-05
$41.30M
derived: sum of 3 quarters · filed 2016-11-14
$54.31M
derived: sum of 4 quarters · filed 2016-11-14
2014-03-31$15.96M
10-K · filed 2016-11-14
$30.70M
derived: sum of 2 quarters · filed 2016-11-14
$43.70M
derived: sum of 3 quarters · filed 2016-11-14
$53.28M
derived: sum of 4 quarters · filed 2016-11-14
2013-12-31$14.74M
10-K · filed 2015-02-23
$27.74M
derived: sum of 2 quarters · filed 2015-02-23
$37.32M
derived: sum of 3 quarters · filed 2015-02-23
$48.97M
10-K · filed 2016-11-14
2013-09-30$13.01M
10-K · filed 2015-02-23
$22.59M
derived: sum of 2 quarters · filed 2015-02-23
$34.24M
10-Q · filed 2014-10-31
$47.87M
derived: sum of 4 quarters · filed 2015-02-23
2013-06-30$9.58M
10-K · filed 2015-02-23
$21.23M
10-Q · filed 2014-08-05
$34.87M
derived: sum of 3 quarters · filed 2015-02-23
$41.24M
derived: sum of 4 quarters · filed 2015-02-23
2013-03-31$11.65M
10-K · filed 2015-02-23
$25.29M
derived: sum of 2 quarters · filed 2015-02-23
$31.66M
derived: sum of 3 quarters · filed 2015-02-23
$37.40M
derived: sum of 4 quarters · filed 2015-02-23
2012-12-31$13.63M
10-K/A · filed 2014-12-12
$20.01M
derived: sum of 2 quarters · filed 2014-12-12
$25.75M
derived: sum of 3 quarters · filed 2014-12-12
$31.39M
10-K · filed 2015-02-23
2012-09-30$6.38M
10-K/A · filed 2014-12-12
$12.12M
derived: sum of 2 quarters · filed 2014-12-12
$17.75M
10-Q · filed 2013-11-08
$30.69M
derived: sum of 4 quarters · filed 2014-12-12
2012-06-30$5.74M
10-K/A · filed 2014-12-12
$11.38M
10-Q · filed 2013-08-01
$24.32M
derived: sum of 3 quarters · filed 2014-12-12
$30.06M
derived: sum of 4 quarters · filed 2014-12-12
2012-03-31$5.64M
10-K/A · filed 2014-12-12
$18.57M
derived: sum of 2 quarters · filed 2014-12-12
$24.31M
derived: sum of 3 quarters · filed 2014-12-12
$31.78M
derived: sum of 4 quarters · filed 2014-12-12
2011-12-31$12.94M
10-K · filed 2013-03-14
$18.68M
derived: sum of 2 quarters · filed 2013-03-14
$26.14M
derived: sum of 3 quarters · filed 2013-03-14
$30.04M
10-K/A · filed 2014-12-12
2011-09-30$5.74M
10-K · filed 2013-03-14
$13.20M
derived: sum of 2 quarters · filed 2013-03-14
$17.10M
10-Q · filed 2012-11-14
$21.04M
derived: sum of 4 quarters · filed 2013-03-14
2011-06-30$7.46M
10-K · filed 2013-03-14
$11.36M
10-Q/A · filed 2012-11-14
$15.30M
derived: sum of 3 quarters · filed 2013-03-14
$23.10M
derived: sum of 4 quarters · filed 2013-03-14
2011-03-31$3.90M
10-K · filed 2013-03-14
$7.84M
derived: sum of 2 quarters · filed 2013-03-14
$15.64M
derived: sum of 3 quarters · filed 2013-03-14
$21.48M
derived: sum of 4 quarters · filed 2013-03-14
2010-12-31$3.94M
derived: 10-K 12 month − 10-Q/A 9 month · filed 2013-03-14
$11.74M
derived: sum of 2 quarters · filed 2013-03-14
$17.58M
derived: sum of 3 quarters · filed 2013-03-14
$23.54M
10-K · filed 2013-03-14
2010-09-30$7.80M
10-Q/A · filed 2012-02-10
$13.64M
derived: sum of 2 quarters · filed 2012-02-10
$19.60M
10-Q/A · filed 2012-02-10
2010-06-30$5.84M
10-Q/A · filed 2012-02-10
$11.80M
10-Q/A · filed 2012-02-10
2009-12-31$38.94M
10-K/A · filed 2012-11-14